UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Evolving resistance landscape in gram‐negative pathogens: An update on β‐lactam and β‐lactam‐inhibitor treatment combinations for carbapenem‐resistant organisms

Pharmacotherapy, 2024-08, Vol.44 (8), p.658-674

2024

Volltextzugriff (PDF)

A guide to therapeutic drug monitoring of β‐lactam antibiotics

Pharmacotherapy, 2021-02, Vol.41 (2), p.220-233

2021

Volltextzugriff (PDF)

Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions

The Lancet infectious diseases, 2014-06, Vol.14 (6), p.498-509

2014

Volltextzugriff (PDF)

Ampicillin-sulbactam against Acinetobacter baumannii infections: pharmacokinetic/pharmacodynamic appraisal of current susceptibility breakpoints and dosing recommendations

Journal of antimicrobial chemotherapy, 2024-09, Vol.79 (9), p.2227-2236

2024

Volltextzugriff (PDF)

Optimizing antibiotic dosing regimens for nosocomial pneumonia: a window of opportunity for pharmacokinetic and pharmacodynamic modeling

Expert opinion on drug metabolism & toxicology, 2023-01, Vol.19 (1), p.13-25

2023

Volltextzugriff (PDF)

Pharmacodynamic Thresholds for Beta-Lactam Antibiotics: A Story of Mouse Versus Man

Frontiers in pharmacology, 2022-03, Vol.13, p.833189-833189

2022

Volltextzugriff (PDF)

Minocycline pharmacodynamics against Stenotrophomonas maltophilia in the neutropenic murine infection model: implications for susceptibility breakpoints

Journal of antimicrobial chemotherapy, 2022-03, Vol.77 (4), p.1052-1060

2022

Volltextzugriff (PDF)

Levofloxacin pharmacodynamics against Stenotrophomonas maltophilia in a neutropenic murine thigh infection model: implications for susceptibility breakpoint revision

Journal of antimicrobial chemotherapy, 2021-12, Vol.77 (1), p.164-168

2021

Volltextzugriff (PDF)

Carbapenem-Nonsusceptible Pseudomonas aeruginosa Isolates from Intensive Care Units in the United States: a Potential Role for New β-Lactam Combination Agents

Journal of clinical microbiology, 2019-08, Vol.57 (8)

2019

Volltextzugriff (PDF)

Continuous and Prolonged Intravenous β-Lactam Dosing: Implications for the Clinical Laboratory

Clinical microbiology reviews, 2016-10, Vol.29 (4), p.759-772

2016

Volltextzugriff (PDF)

In vitro activity of imipenem/relebactam against Pseudomonas aeruginosa isolated from patients with cystic fibrosis

Antimicrobial agents and chemotherapy, 2023-11, Vol.67 (11), p.e0092023-e0092023

2023

Volltextzugriff (PDF)

Clinical Pharmacodynamics of Antipseudomonal Cephalosporins in Patients with Ventilator-Associated Pneumonia

Antimicrobial Agents and Chemotherapy, 2014-03, Vol.58 (3), p.1359-1364

2014

Volltextzugriff (PDF)

Clinical Pharmacodynamics of Meropenem in Patients with Lower Respiratory Tract Infections

Antimicrobial Agents and Chemotherapy, 2007-05, Vol.51 (5), p.1725-1730

2007

Volltextzugriff (PDF)

Non-KPC Attributes of Newer β-lactam/β-lactamase Inhibitors, Part 1: Enterobacterales and Pseudomonas aeruginosa

Clinical infectious diseases, 2024-07, Vol.79 (1), p.33-42

2024

Volltextzugriff (PDF)

Clinical Determinants of Target Non-Attainment of Linezolid in Plasma and Interstitial Space Fluid: A Pooled Population Pharmacokinetic Analysis with Focus on Critically Ill Patients

Clinical pharmacokinetics, 2017-06, Vol.56 (6), p.617-633

2017

Volltextzugriff (PDF)

In Vitro Activity of Imipenem-Relebactam Alone or in Combination with Amikacin or Colistin against Pseudomonas aeruginosa

Antimicrobial agents and chemotherapy, 2019-09, Vol.63 (9)

2019

Volltextzugriff (PDF)

Optimised cefiderocol exposures in a successfully treated critically ill patient with polymicrobial Stenotrophomonas maltophilia bacteraemia and pneumonia receiving continuous venovenous haemodiafiltration

International journal of antimicrobial agents, 2021-09, Vol.58 (3), p.106395-106395, Article 106395

2021

Volltextzugriff (PDF)

Bronchopulmonary disposition of IV cefepime/taniborbactam (2–0.5 g) administered over 2 h in healthy adult subjects

Journal of antimicrobial chemotherapy, 2023-03, Vol.78 (3), p.703-709

2023

Volltextzugriff (PDF)

Imipenem/cilastatin/relebactam pharmacokinetics in critically ill patients with augmented renal clearance

Journal of antimicrobial chemotherapy, 2022-10, Vol.77 (11), p.2992-2999

2022

Volltextzugriff (PDF)

Effects of clinically achievable pulmonary antibiotic concentrations on the recovery of bacteria: in vitro comparison of the BioFire FILMARRAY Pneumonia Panel versus conventional culture methods in bronchoalveolar lavage fluid

Journal of clinical microbiology, 2024-01, Vol.62 (1), p.e0113323

2024

Volltextzugriff (PDF)

Antioxidant compounds from four Opuntia cactus pear fruit varieties

Food chemistry, 2004, Vol.85 (4), p.527-533

Kuti, Joseph O

2004

Volltextzugriff (PDF)

Trimethoprim/sulfamethoxazole pharmacodynamics against Stenotrophomonas maltophilia in the in vitro chemostat model

Journal of antimicrobial chemotherapy, 2022-10, Vol.77 (11), p.3187-3193

2022

Volltextzugriff (PDF)

Imipenem/Cilastatin/Relebactam Alone and in Combination against Pseudomonas aeruginosa in the In Vitro Pharmacodynamic Model

Antimicrobial agents and chemotherapy, 2020-11, Vol.64 (12)

2020

Volltextzugriff (PDF)

Plazomicin: an intravenous aminoglycoside antibacterial for the treatment of complicated urinary tract infections

Expert review of anti-infective therapy, 2020-08, Vol.18 (8), p.705-720

2020

Volltextzugriff (PDF)

Population pharmacokinetics of piperacillin/tazobactam in critically ill young children

The Pediatric infectious disease journal, 2014-02, Vol.33 (2), p.168-173

2014

Volltextzugriff (PDF)

1 – 25 von 352

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(339)
Mit Volltextzugriff
(284)

Publikationsform

Sprache

Englisch
(351)
Spanisch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(229)
Life Sciences & Biomedicine
(228)
Humans
(176)
Pharmacology & Pharmacy
(148)
Infectious Diseases
(98)
Microbiology
(98)
Biological And Medical Sciences
(86)
Microbial Sensitivity Tests
(81)
Medical Sciences
(76)
Female
(70)
Male
(69)
Pharmacology. Drug Treatments
(65)
Anti-Bacterial Agents - Pharmacokinetics
(64)
Pharmacodynamics
(64)
Anti-Bacterial Agents - Pharmacology
(61)
Anti-Bacterial Agents - Administration & Dosage
(57)
Antibiotics
(57)
Middle Aged
(55)
Monte Carlo Method
(54)
Anti-Bacterial Agents - Therapeutic Use
(52)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(189)
EZB Electronic Journals Library
(155)
Journals@Ovid Complete
(140)
IngentaConnect
(110)
Publisher website
(67)
Elsevier ScienceDirect Journals Complete
(57)
Wiley Online Library Journals Frontfile Complete
(39)
Wiley Online Library
(38)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(37)
Oxford Journals
(35)
Oxford Journals 2020 Medicine
(34)
IngentaConnect Journals
(30)
SpringerLink
(23)
Nexis Uni
(14)
Taylor & Francis Journals
(14)
JSTOR
(13)
SAGE Complete
(11)
Taylor & Francis
(11)
Business Source Ultimate
(10)
Taylor & Francis Online
(9)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Evolving resistance landscape in gram‐negative pathogens: An update on β‐lactam and β‐lactam‐inhibitor treatment combinations for carbapenem‐resistant organisms

A guide to therapeutic drug monitoring of β‐lactam antibiotics

Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions

Ampicillin-sulbactam against Acinetobacter baumannii infections: pharmacokinetic/pharmacodynamic appraisal of current susceptibility breakpoints and dosing recommendations

Optimizing antibiotic dosing regimens for nosocomial pneumonia: a window of opportunity for pharmacokinetic and pharmacodynamic modeling

Pharmacodynamic Thresholds for Beta-Lactam Antibiotics: A Story of Mouse Versus Man

Minocycline pharmacodynamics against Stenotrophomonas maltophilia in the neutropenic murine infection model: implications for susceptibility breakpoints

Levofloxacin pharmacodynamics against Stenotrophomonas maltophilia in a neutropenic murine thigh infection model: implications for susceptibility breakpoint revision

Carbapenem-Nonsusceptible Pseudomonas aeruginosa Isolates from Intensive Care Units in the United States: a Potential Role for New β-Lactam Combination Agents

Continuous and Prolonged Intravenous β-Lactam Dosing: Implications for the Clinical Laboratory

In vitro activity of imipenem/relebactam against Pseudomonas aeruginosa isolated from patients with cystic fibrosis

Clinical Pharmacodynamics of Antipseudomonal Cephalosporins in Patients with Ventilator-Associated Pneumonia

Clinical Pharmacodynamics of Meropenem in Patients with Lower Respiratory Tract Infections

Non-KPC Attributes of Newer β-lactam/β-lactamase Inhibitors, Part 1: Enterobacterales and Pseudomonas aeruginosa

Clinical Determinants of Target Non-Attainment of Linezolid in Plasma and Interstitial Space Fluid: A Pooled Population Pharmacokinetic Analysis with Focus on Critically Ill Patients

In Vitro Activity of Imipenem-Relebactam Alone or in Combination with Amikacin or Colistin against Pseudomonas aeruginosa

Optimised cefiderocol exposures in a successfully treated critically ill patient with polymicrobial Stenotrophomonas maltophilia bacteraemia and pneumonia receiving continuous venovenous haemodiafiltration

Bronchopulmonary disposition of IV cefepime/taniborbactam (2–0.5 g) administered over 2 h in healthy adult subjects

Imipenem/cilastatin/relebactam pharmacokinetics in critically ill patients with augmented renal clearance

Effects of clinically achievable pulmonary antibiotic concentrations on the recovery of bacteria: in vitro comparison of the BioFire FILMARRAY Pneumonia Panel versus conventional culture methods in bronchoalveolar lavage fluid

Antioxidant compounds from four Opuntia cactus pear fruit varieties

Trimethoprim/sulfamethoxazole pharmacodynamics against Stenotrophomonas maltophilia in the in vitro chemostat model

Imipenem/Cilastatin/Relebactam Alone and in Combination against Pseudomonas aeruginosa in the In Vitro Pharmacodynamic Model

Plazomicin: an intravenous aminoglycoside antibacterial for the treatment of complicated urinary tract infections

Population pharmacokinetics of piperacillin/tazobactam in critically ill young children

Suchergebnisse filtern